natgillin/translations-raw huggingface dataset:
Annex II is amended in accordance with Annex II to this Decision.
Priloga II se spremeni v skladu s Prilogo II k tej odločbi.
In Annex I to Decision 2008/911/EC, the following is inserted:
V Prilogo I k Odločbi 2008/911/ES se vstavi:
‘Calendula officinalis L’ is inserted before Foeniculum vulgare Miller subsp. vulgare var. vulgare (Bitter fennel, fruit),
„Calendula officinalis L.“ pred Foeniculum vulgare Miller subsp. vulgare var. Vulgare (grenki navadni komarček, plod)
‘Pimpinella anisum L’ is inserted after Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (Sweet fennel, fruit).
„Pimpinella anisum L.“ pred Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (sladki navadni komarček, plod).
In Annex II to Decision 2008/911/EC, the following is inserted:
V Prilogo II k Odločbi 2008/911/ES se vstavi:
‘Calendula officinalis L’ is inserted before Foeniculum vulgare Miller subsp. vulgare var. vulgare (Bitter fennel, fruit)
„Calendula officinalis L.“ pred Foeniculum vulgare Miller subsp. vulgare var. Vulgare (grenki navadni komarček, plod).
‘COMMUNITY LIST ENTRY ON CALENDULA OFFICINALIS L
„VPIS V SEZNAM SKUPNOSTI CALENDULA OFFICINALIS L
Calendula flower
Cvet vrtnega ognjiča
Herbal preparation(s)
Pripravki rastlinskega izvora
Liquid extract (DER 1:1), extraction solvent ethanol 40-50 % (v/v).
Tekoči ekstrakt (DER 1:1), ekstrakcijsko topilo etanol 40–50 % (V/V)
Liquid extract (DER 1:1,8-2,2), extraction solvent ethanol 40-50 % (v/v).
Tekoči ekstrakt (DER 1:1,8–2,2), ekstrakcijsko topilo etanol 40–50 % (V/V)
Tincture (DER 1:5), extraction solvent ethanol 70-90 % (v/v).
Tinktura (DER 1:5), ekstrakcijsko topilo etanol 70–90 % (V/V)
European Pharmacopoeia monograph reference
Sklic na monografijo Evropske farmakopeje
Indication(s)
Indikacije
Traditional herbal medicinal product for the symptomatic treatment of minor inflammations of the skin (such as sunburn) and as an aid in healing of minor wounds.
Tradicionalno zdravilo rastlinskega izvora za simptomatsko zdravljenje blagih vnetij kože (kot so sončne opekline) in kot pomoč pri zdravljenju manjših ran.
Traditional herbal medicinal product for the symptomatic treatment of minor inflammations in the mouth or the throat.
Tradicionalno zdravilo rastlinskega izvora za simptomatsko zdravljenje manjših vnetij v ustih ali žrelu.
European
Evropska
Please see “Specified posology”.
Glejte ‚Odmerjanje‘.
Herbal preparations:
Pripravki rastlinskega izvora:
Liquid extract (DER 1:1)
Tekoči ekstrakt (DER 1:1)
In semi-solid dosage forms: amount equivalent to 2-10 % herbal substance.
V poltekočih oblikah odmerjanja: količina, ki ustreza od 2 do 10 % rastlinske snovi.
Liquid extract (DER 1:1,8-2,2)
Tekoči ekstrakt (DER 1:1,8–2,2)
In semi-solid dosage forms: amount equivalent to 2-5 % herbal substance.
V poltekočih oblikah odmerjanja: količina, ki ustreza od 2 do 5 % rastlinske snovi
Tincture (DER 1:5)
Tinktura (DER 1:5)
In compresses diluted at least 1:3 with freshly boiled water.
V obliki oblog, raztopljenih s sveže prekuhano vodo v razmerju najmanj 1:3.
As a gargle or mouth rinse in a 2 % solution.
Kot 2-odstotna raztopina za grgranje ali izpiranje ust.
2 to 4 times daily
Dvakrat do štirikrat dnevno.
The use is not recommended in children under 6 years of age (see below “Special warnings and precautions for use”).
Uporaba pri otrocih, mlajših od 6 let, ni priporočljiva (glejte poglavje ‚Posebna opozorila in previdnostni ukrepi‘).
The use in children under 12 years of age is not recommended because there is no experience available (see below “Special warnings and precautions for use”).
Uporaba pri otrocih, mlajših od 12 let, ni priporočljiva, ker ni na voljo nobenih izkušenj (glejte poglavje ‚Posebna opozorila in previdnostni ukrepi‘).
Cutaneous and oromucosal use.
Dermalna in oralna uporaba.
Compresses: remove after 30-60 minutes
Obloge: odstranite po 30–60 minutah.
All herbal preparations: If the symptoms persist after 1 week during the use of the medicinal product a doctor or a qualified health care practitioner should be consulted.
Vsi pripravki rastlinskega izvora: če simptomi med uporabo zdravila po 1 tednu ne popustijo, se je treba posvetovati z zdravnikom ali usposobljenim zdravstvenim delavcem.
Hypersensitivity to members of the Asteraceae (Compositae) family.
Preobčutljivost na rastline iz skupine nebinovk – Asteraceae (Compositae).
The use in children under 6 years of age is not recommended because there is no experience available.
Uporaba pri otrocih, mlajših od 6 let, ni priporočljiva, ker ni na voljo nobenih izkušenj.
The use in children under 12 years of age is not recommended because there is no experience available.
Uporaba pri otrocih, mlajših od 12 let, ni priporočljiva, ker ni na voljo nobenih izkušenj.
If signs of skin infection are observed, a doctor or a qualified health care practitioner should be consulted.
Če se pojavijo znaki vnetja kože, se je treba posvetovati z zdravnikom ali usposobljenim zdravstvenim delavcem.
Safety during pregnancy and lactation has not been established.
Varnost med nosečnostjo in dojenjem ni bila ugotovljena.
Not relevant.
Navedba smiselno ni potrebna.
Skin sensitisation.
Preobčutljivost kože.
If other adverse reactions not mentioned above occur, a doctor or a qualified health care practitioner should be consulted.
Če se pojavijo drugi neželeni učinki, ki niso navedeni zgoraj, se je treba posvetovati z zdravnikom ali usposobljenim zdravstvenim delavcem.
None reported.’
Ni poročil.“
‘Pimpinella anisum L’ is inserted after Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (Sweet fennel, fruit)
„Pimpinella anisum L.“ se vstavi pred Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (sladki navadni komarček, plod).
‘COMMUNITY LIST ENTRY ON PIMPINELLA ANISUM L
„VPIS V SEZNAM SKUPNOSTI PIMPINELLA ANISUM L
Aniseed
Plod vrtnega janeža
Dried aniseed, comminuted or crushed
Posušen, zdrobljen ali strt plod vrtnega janeža
Traditional herbal medicinal product used as an expectorant in cough associated with cold.
Tradicionalno zdravilo rastlinskega izvora, ki se uporablja kot ekspektorans (zdravilo za lažje izkašljevanje) pri kašlju, povezanim s prehladom.
Please see “Specified posology”
Glejte ‚Odmerjanje‘
Adolescents over 12 years of age, adults, elderly:
Mladostniki nad 12 let, odrasli, starejši:
Indications (a) and (b)
Indikaciji (a) in (b)
1 to 3,5 g of whole or (freshly) comminuted or crushed aniseed in 150 ml of boiling water as a herbal tea 3 times daily
1 do 3,5 g celih ali (sveže) zdrobljenih ali strtih plodov vrtnega janeža s 150 ml vrele vode kot zdravilni čaj. Trikrat dnevno.
The use in children under 12 years is not recommended of age (see below “Special warnings and precautions for use”).
Uporaba pri otrocih, mlajših od 12 let, ni priporočljiva (glejte poglavje ‚Posebna opozorila in previdnostni ukrepi‘).
Oral use
Peroralna uporaba
Not to be taken for more than 2 weeks.
Zdravilo se ne sme jemati dlje kot 2 tedna.
If the symptoms persist during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted.
Če simptomi med uporabo zdravila ne popustijo, se je treba posvetovati z zdravnikom ali usposobljenim zdravstvenim delavcem.
Hypersensitivity to the active substance or to Apiaceae (Umbelliferae) (caraway, celery, coriander, dill and fennel) or to anethole.
Preobčutljivost na zdravilno učinkovino ali na rastline iz skupine kobulnic – Apiaceae (Umbelliferae) (kumina, zelena, koriander, koper in komarček) ali na anetol.
The use is not recommended in children under 12 years of age due to the lack of adequate data for safety assessment.
Zaradi pomanjkanja ustreznih podatkov uporaba pri otrocih, mlajših od 12 let, ni priporočljiva.
There are no data from the use of aniseed in pregnant patients.
Ni podatkov o uporabi vrtnega janeža pri nosečnicah.
It is unknown if aniseed constituents are excreted in human breast milk.
Ni znano, ali se sestavine vrtnega janeža izločajo v materino mleko.
Allergic reactions to aniseed affecting the skin or the respiratory system may occur.
Možne so preobčutljivostne reakcije na vrtni janež, ki prizadenejo kožo ali dihalni sistem.
For commercial preparations of comminuted or crushed aniseed the applicant must carry out appropriate stability testing related to the content of essential oil components.’
Za komercialni pripravek zdrobljenih ali strtih plodov vrtnega janeža mora predlagatelj izvesti ustrezno preskušanje stabilnosti glede vsebnosti komponent eteričnih olj.“
on the paying-up of the European Central Bank’s capital by the non-euro area national central banks
o vplačilu kapitala Evropske centralne banke s strani nacionalnih centralnih bank zunaj euroobmočja
Having regard to the Statute of the European System of Central Banks and of the European Central Bank (hereinafter the ‘Statute of the ESCB’), and in particular Article 47 thereof,
ob upoštevanju Statuta Evropskega sistema centralnih bank in Evropske centralne banke (v nadaljnjem besedilu: Statut ESCB) ter zlasti člena 47 Statuta ESCB,
Article 47 of the Statute of the ESCB provides that central banks of Member States with a derogation (hereinafter ‘non-euro area NCBs’) do not need to pay up their subscribed capital unless the General Council, acting by a majority representing at least two thirds of the subscribed capital of the European Central Bank (ECB) and at least half of the shareholders, decides that a minimal percentage has to be paid up as a contribution to the ECB’s operational costs.
Člen 47 Statuta ESCB določa, da centralne banke držav članic z odstopanjem (v nadaljnjem besedilu: NCB zunaj euroobmočja) ne vplačajo svojega vpisanega kapitala, razen če Razširjeni svet z večino, ki predstavlja vsaj dve tretjini vpisanega kapitala Evropske centralne banke (ECB) in vsaj polovico delničarjev, ne odloči, da mora biti vplačan minimalni odstotek kot prispevek za stroške poslovanja ECB.
Article 1 of Decision ECB/2008/28 of 15 December 2008 laying down the measures necessary for the paying-up of the European Central Bank’s capital by the non-participating national central banks [1] provides that non-euro area NCBs must pay up 7 % of their subscription to the ECB’s capital with effect from 1 January 2009.
Člen 1 Sklepa ECB/2008/28 z dne 15. decembra 2008 o določitvi ukrepov, potrebnih za vplačilo kapitala Evropske centralne banke s strani nesodelujočih nacionalnih centralnih bank [1], določa, da morajo NCB zunaj euroobmočja vplačati 7 % svojega vpisanega kapitala v kapital ECB z učinkom od 1. januarja 2009.
Decision ECB/2008/23 of 12 December 2008 on the national central banks’ percentage shares in the key for subscription to the European Central Bank’s capital [2] lays down the key for subscription to the ECB’s capital in accordance with Article 29.3 of the Statute of the ESCB and establishes with effect from 1 January 2009 the weightings assigned to each national central bank in the capital key (hereinafter the ‘capital key weightings’).
Sklep ECB/2008/23 z dne 12. decembra 2008 o odstotnih deležih nacionalnih centralnih bank v ključu za vpis kapitala Evropske centralne banke [2] določa ključ za vpis kapitala ECB v skladu s členom 29.3 Statuta ESCB in z učinkom od 1. januarja 2009 vzpostavlja ponderje, določene za vsako nacionalno centralno banko v kapitalskem ključu (v nadaljnjem besedilu: ponderji v kapitalskem ključu).
Pursuant to Article 1 of Decision ECB/2010/26 of 13 December 2010 on the increase of the European Central Bank’s capital [3] the ECB’s capital has been increased by EUR 5000 million from EUR 5760652402,58 to EUR 10760652402,58 with effect from 29 December 2010.
V skladu s členom 1 Sklepa ECB/2010/26 z dne 13. decembra 2010 o povečanju kapitala Evropske centralne banke [3] se je kapital ECB povečal za 5000 milijonov EUR, in sicer s 5760652402,58 EUR na 10760652402,58 EUR, z učinkom od 29. decembra 2010.
The increase of the ECB’s capital would require non-euro area NCBs to pay up 7 % of their respective share in the increased capital although the ECB’s operational costs do not justify a higher contribution in absolute terms.
Povečanje kapitala ECB bi zahtevalo, da NCB zunaj euroobmočja vplačajo 7 % njihovega ustreznega deleža v povečanem kapitalu, čeprav stroški poslovanja ECB ne upravičujejo višjega prispevka v absolutnem smislu.
To avoid this increased contribution to the operational costs of the ECB by the non-euro area NCBs, it is necessary to decrease the percentage that non-euro area NCBs have to pay up so that the amounts to be paid up remain on a similar level,
V izogib temu povečanemu prispevku za stroške poslovanja ECB s strani NCB zunaj euroobmočja je treba odstotek, ki ga morajo vplačati NCB zunaj euroobmočja, zmanjšati tako, da zneski, ki jih je treba plačati, ostanejo na podobni ravni –
Non-euro area NCB
NCB zunaj euroobmočja
Subscribed capital as at 29 December 2010
Vpisani kapital na 29. december 2010
Paid-up capital as at 29 December 2010
Vplačani kapital na 29. december 2010
Given that each non-euro area NCB has already paid up 7 % of its share in the ECB’s subscribed capital as applicable on 28 December 2010 under Decision ECB/2008/28, each of them shall pay up the additional amount specified in the below table, which is the difference between the paid-up capital specified in Article 1 and the amount paid up in the past:
Glede na to, da so vse NCB zunaj euroobmočja že vplačale 7 % svojih deležev v vpisanem kapitalu ECB, kot veljajo na 28. december 2010 po Sklepu ECB/2008/28, bo vsaka od njih vplačala dodatni znesek iz spodnje tabele, ki predstavlja razliko med vplačanim kapitalom iz člena 1 in v preteklosti vplačanim zneskom:
Non-euro area NCBs shall pay the amounts specified in paragraph 1 to the ECB by means of a separate transfer via the Trans-European Automated Real-time Gross settlement Express Transfer system (TARGET2) on 29 December 2010.
NCB zunaj euroobmočja plačajo Evropski centralni banki zneske, navedene v odstavku 1, z ločenim prenosom preko transevropskega sistema bruto poravnave v realnem času (sistem TARGET2) 29. decembra 2010.
Where a non-euro area NCB does not have access to TARGET2, the amounts set out in paragraph 1 shall be transferred by crediting an account that the ECB or the non-euro area NCB shall nominate in due time.
Kadar NCB zunaj euroobmočja nima dostopa do sistema TARGET2, se zneski, navedeni v odstavku 1, prenesejo s knjiženjem v dobro računa, ki ga ECB ali NCB zunaj euroobmočja pravočasno določi.
Decision ECB/2008/28 is hereby repealed with effect from 29 December 2010.
Sklep ECB/2008/28 se s tem sklepom razveljavi z učinkom od 29. decembra 2010.
References to Decision ECB/2008/28 shall be construed as references to this Decision.
Sklicevanja na Sklep ECB/2008/28 se štejejo za sklicevanja na ta sklep.
OJ L 21, 24.1.2009, p. 81.
UL L 21, 24.1.2009, str. 81.
Each non-euro area NCB shall pay up 3,75 % of its share in the ECB’s subscribed capital with effect from 29 December 2010.
Vsaka NCB zunaj euroobmočja vplača 3,75 % svojega deleža v vpisanem kapitalu ECB z učinkom od 29. decembra 2010.
Taking into account the capital key weightings laid down in Article 2 of Decision ECB/2008/23, each non-euro area NCB shall have a total subscribed and paid-up capital of the amounts shown next to its name in the following table:
Ob upoštevanju ponderjev v kapitalskem ključu, določenih v členu 2 Sklepa ECB/2008/23, ima vsaka NCB zunaj euroobmočja skupni vpisani in vplačani kapital v zneskih, ki sta prikazana poleg njenega imena v spodnji tabeli:
of 18 January 2010
z dne 18. januarja 2010
Having regard to the Treaty on the Functioning of the European Union, and in particular Articles 300(3) and 305 thereof, in conjunction with Article 8 of the Protocol on Transitional Provisions annexed to the Treaty on European Union and the Treaty on the Functioning of the European Union,
ob upoštevanju Pogodbe o delovanju Evropske unije in zlasti členov 300(3) in 305 Pogodbe ter v povezavi s členom 8 Protokola o prehodni ureditvi, ki je priložen Pogodbi o Evropski uniji in Pogodbi o delovanju Evropske unije,
Article 300(3) of the Treaty on the Functioning of the European Union requires that members or alternate members of the Committee of the Regions, besides being representatives of regional or local bodies, ‘either hold a regional or local authority electoral mandate or are politically accountable to an elected assembly’.
Člen 300(3) Pogodbe o delovanju Evropske unije predvideva, da morajo biti člani ali nadomestni člani Odbora regij predstavniki regionalnih ali lokalnih organov, in da so bodisi nosilci volilnega mandata ali pa so politično odgovorni izvoljeni skupščini.
Article 305 of the Treaty on the Functioning of the European Union provides for the members of the Committee and an equal number of alternate members to be appointed by the Council for five years in accordance with the proposals made by each Member State.
Člen 305 Pogodbe o delovanju Evropske unije predvideva, da Svet v skladu s predlogi držav članic imenuje člane odbora in enako število nadomestnih članov za dobo petih let.
Article 8 of the Protocol on Transitional Provisions sets out the allocation of members of the Committee of the Regions.
V členu 8 Protokola o prehodni ureditvi je določena razdelitev članov Odbora regij.
As the term of office of the members and alternate members of the Committee of the Regions is due to expire on 25 January 2010, new members and alternate members should be appointed to the Committee of the Regions.
Mandat članov in nadomestnih članov Odbora regij se izteče 25. januarja 2010, zato bi bilo treba imenovati nove člane in nadomestne člane Odbora regij.
On 22 December 2009, the Council adopted the proposals of members and alternate members submitted by the Belgian, Bulgarian, Czech, Danish, Estonian, Greek, Spanish, French, Italian, Cypriot, Latvian, Lithuanian, Luxembourg, Hungarian, Maltese, Dutch, Austrian, Polish, Portuguese, Romanian, Slovenian, Slovak, Finnish, Swedish and British Governments and the list containing 24 members and 23 alternate members submitted by the German Government [1].
Svet je 22. decembra 2009 sprejel predloge za imenovanje članov in nadomestnih članov, ki so jih predložile vlade Belgije, Bolgarije, Češke, Danske, Estonije, Grčije, Španije, Francije, Italije, Cipra, Latvije, Litve, Luksemburga, Madžarske, Malte, Nizozemske, Avstrije, Poljske, Portugalske, Romunije, Slovenije, Slovaške, Finske, Švedske in Združenega kraljestva, ter seznam 24 članov in 23 nadomestnih članov, ki ga je predložila nemška vlada [1].
The members and alternate members proposed by the Irish government as well as one alternate member proposed by the German government, should now be appointed to the Committee of the Regions,
Treba bi bilo imenovati člane in nadomestne člane Odbora regij, ki jih je predlagala irska vlada, ter nadomestnega člana, ki ga je predlagala nemška vlada –
The following are hereby appointed to the Committee of the Regions for the period from 26 January 2010 to 25 January 2015:
V Odbor regij se za obdobje od 26. januarja 2010 do 25. januarja 2015:
as members, the persons listed by Member State in Annex I,
za člane imenujejo osebe, katerih seznam po državah članicah se nahaja v Prilogi I,
as alternate members, the persons listed by Member State in Annex II.
za nadomestne člane imenujejo osebe, katerih seznam po državah članicah se nahaja v Prilogi II.
It shall enter into force on the date of its adoption.
Veljati začne na dan sprejetja.
Done at Brussels, 18 January 2010.
V Bruslju, 18. januarja 2010
The President
Predsednice
OJ L 348, 29.12.2009, p. 22.
UL L 348, 29.12.2009, str. 22.
on the issue of euro banknotes
o izdajanju eurobankovcev
Under Article 128(1) of the Treaty and Article 16 of the Statute of the ESCB, the Governing Council of the European Central Bank (ECB) has the exclusive right to authorise the issue of euro banknotes within the Union.
V skladu s členom 128(1) Pogodbe in členom 16 Statuta ESCB ima Svet Evropske centralne banke (ECB) izključno pravico odobriti izdajanje eurobankovcev v Uniji.
Under these provisions, the ECB and the NCBs may issue euro banknotes which are the only banknotes to have the status of legal tender within the Member States whose currency is the euro.
V skladu s tema določbama lahko ECB in nacionalne centralne banke (NCB) izdajajo eurobankovce, ki so edini bankovci s statusom zakonitega plačilnega sredstva v državah članicah, katerih valuta je euro.
Union law has foreseen a system of a plurality of issuers of banknotes.
Pravo Unije predvideva sistem pluralnosti izdajateljev bankovcev.
The ECB and the NCBs issue euro banknotes.
Eurobankovce izdajajo ECB in NCB.
Pursuant to Article 10 of Council Regulation (EC) No 974/98 of 3 May 1998 on the introduction of the euro [1], on 1 January 2002, the ECB and the NCBs put into circulation banknotes denominated in euro.
Na podlagi člena 10 Uredbe Sveta (ES) št. 974/98 z dne 3. maja 1998 o uvedbi eura [1] so ECB in NCB 1. januarja 2002 dale v obtok bankovce, denominirane v eurih.
Euro banknotes are expressions of the same and single currency, and subject to a single legal regime.
Eurobankovci so izraz iste in enotne valute in zanje velja enoten pravni režim.
The issue of euro banknotes need not be subject to quantitative or other limits, since putting banknotes into circulation is a demand driven process.
Za izdajanje bankovcev niso potrebne količinske ali druge omejitve, saj je dajanje bankovcev v obtok proces, ki ga uravnava povpraševanje.
Decision ECB/2003/4 of 20 March 2003 on the denominations, specifications, reproduction, exchange and withdrawal of euro banknotes [2] contains common rules on euro banknotes.
Sklep ECB/2003/4 z dne 20. marca 2003 o apoenih, specifikacijah, reprodukciji, zamenjavi in jemanju eurobankovcev iz obtoka [2] vsebuje skupna pravila o eurobankovcih.
The ECB has established common technical specifications for euro banknotes and quality control measures to ensure that they comply with such specifications.
ECB je uvedla skupne tehnične specifikacije za eurobankovce in ukrepe za nadzor kakovosti, da bi zagotovila skladnost eurobankovcev s temi specifikacijami.
As a consequence, all euro banknotes have the same physical appearance and level of quality and there is no distinction between banknotes of the same denomination.
Zato so vsi eurobankovci enakega izgleda in ravni kakovosti, med bankovci istega apoena pa ni nobenih razlik.
All euro banknotes should be subject to identical acceptance and processing requirements by the Eurosystem members irrespective of which member put them into circulation.
Za vse eurobankovce bi morale veljati enake zahteve članic Eurosistema glede sprejemanja in obdelovanja, ne glede na to, katera od njih jih je dala v obtok.
The practice of repatriation of banknotes denominated in national currency units to the issuing central bank does not apply to euro banknotes.
Postopek repatriacije bankovcev, denominiranih v enotah nacionalnih valut, centralni banki izdajateljici za eurobankovce ne velja.
The regime for the issue of the euro banknotes is based on the principle of non-repatriation of euro banknotes.
Ureditev izdajanja eurobankovcev temelji na načelu ne-repatriacije eurobankovcev.